Biomerica rises on distribution agreement for bacterial infection test in Canada

Biomerica

24/06/2021 14:08

** Shares of diagnostic co  BMRA.O  up 3.8% at $4.30
premarket
    ** Co signs an exclusive five-year agreement with a Canadian
partner for distribution and marketing Biomerica's new test for
identification and monitoring of H. pylori infection
 urn:newsml:reuters.com:*:nGNX2hCVnz
    ** H. pylori infection is a bacterial infection that causes
stomach inflammation (gastritis), peptic ulcer disease, and
certain types of stomach cancer 
    ** BMRA's distribution partner will seek Health Canada
clearance; Biomerica also intends to seek marketing approval in
the EU and the U.S. 
    ** Stock was down ~17% this year, as of last close

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))